BBNX - Beta Bionics, Inc.
NEXT EARNINGS:
May 12, 2026
EPS Est: $-0.49
|
Rev Est: $26.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$22.38
DETAILS
HIGH:
$32.00
LOW:
$14.00
MEDIAN:
$23.00
CONSENSUS:
$22.38
UPSIDE:
67.14%
Market Cap:
589.49M
Volume:
998,614
Avg Volume:
1,228,433
52 Week Range:
8.89-32.71
Sector:
Healthcare
Industry:
Medical - Equipment & Services
Beta:
5.65
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
352
IPO Date:
2025-01-30
EPS (TTM):
-1.81
P/E Ratio:
-16.87
Revenue (TTM):
100.25M
Total Assets:
328.74M
Total Debt:
12.67M
Cash & Equiv:
31.68M
Rev Growth (5Y):
723.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-24.1%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-17 | $-0.30 | $-0.42 | +28.6% | $32.1M | $27.1M | +18.5% |
| 2025-10-28 | $-0.33 | $-0.45 | +26.7% | $27.3M | $28.9M | -5.7% |
| 2025-07-29 | $-0.39 | $-0.51 | +23.5% | $23.2M | $21.9M | +6.1% |
| 2025-05-06 | $-0.52 | $-0.51 | -2.0% | $17.6M | $19.7M | -10.4% |
| 2025-03-25 | $-1.82 | $-0.42 | -333.3% | $20.4M | $16.1M | +26.6% |
| 2025-01-31 | $-1.55 | — | — | $16.7M | — | — |
| 2023-12-31 | $-3.13 | — | — | $8.3M | — | — |
| 2023-09-30 | $-1.71 | — | — | $3.1M | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 100.25M | 65.12M | 11.99M | 179,000 |
| Net Income | (73.20M) | (54.76M) | (44.10M) | (64.75M) |
| EPS | -1.81 | -8.60 | -8.31 | -12.96 |
| Total Assets | 328.74M | 149.65M | 110.04M | 35.53M |
| Total Debt | 12.67M | 7.25M | 4.22M | 4.13M |
| Cash & Equivalents | 31.68M | 30.43M | 26.57M | 27.68M |
| Operating Cash Flow | 0 | (48.27M) | (32.45M) | (60.21M) |
| Free Cash Flow | 0 | (51.67M) | (32.85M) | (60.98M) |
| FCF per Share | N/A | -8.12 | -6.19 | -12.20 |
| Book Value | 287.61M | 76.01M | 58.61M | 13.00M |
| Cash & ST Investments | 219.22M | 103.58M | 96.75M | 27.68M |
| ROC Equity | -0.25 | -0.72 | -0.75 | -4.98 |